Search Within

Andrew D Zelenetz

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (43)
  2. Journal Article (36)
  3. Research Letter (3)
Groups
  1. Center for Hematologic Malignancies (82)
  2. Department of Medicine (82)
  3. Hematologic Malignancies, Division of (82)
  4. Lymphoma (82)
  5. Molecular Imaging and Therapy Service (82)
  6. Radiology, Department of (82)

More Groups

People
  1. Heiko Schoder (66)
  2. Paul Hamlin (52)
  3. Ariela Noy (49)
  4. Anita Kumar (46)
  5. David Straus (46)
  6. Steven Horwitz (46)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (9)
  4. 2022 (5)
  5. 2021 (8)
  6. 2020 (4)

More Years

Publications
  1. Blood (34)
  2. Journal of Clinical Oncology (13)
  3. Hematological Oncology (7)
  4. Annals of Oncology (4)
  5. Journal of Nuclear Medicine (4)
  6. Haematologica (3)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. American Society of Clinical Oncology (13)
  3. Wiley Blackwell (8)
  4. Oxford University Press (4)
  5. Society of Nuclear Medicine (4)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (82)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma
    Journal Article

    Moskowitz, C. H.; Schoder, H.; Teruya-Feldstein, J.; Sima, C.; Iasonos, A.; Portlock, C. S.; Straus, D.; Noy, A.; Palomba, M. L.; O'Connor, O. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The prognostic value of residual FDG-avidity prior to allogeneic stem cell transplantation for lymphoma
    Meeting Abstract

    Sauter, C. S.; Barker, J. N.; Zelenetz, A. D.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
    Blood (2009)

    Fulltext@MSK | Save
  • NCCN Task Force report: Positron emission tomography (PET)/computed tomography (CT) scanning in cancer
    Journal Article

    Podoloff, D. A.; Advani, R. H.; Allred, C.; Benson, A. B. 3rd; Brown, E.; Burstein, H. J.; Carlson, R. W.; Coleman, R. E.; Czuczman, M. S.; Delbeke, D.; more...
    Journal of the National Comprehensive Cancer Network (2007)

    Fulltext@MSK | Save
  • FDG-PET Lymphoma Demonstration Project Invitational Workshop
    Journal Article

    Kelloff, G. J.; Sullivan, D. M.; Wilson, W.; Cheson, B.; Juweid, M.; Mills, G. Q.; Zelenetz, A. D.; Horning, S. J.; Weber, W.; Sargent, D. J.; more...
    Academic Radiology (2007)

    Fulltext@MSK | Save
  • Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma
    Journal Article

    Iwamoto, F. M.; Schwartz, J.; Pandit-Taskar, N.; Peak, S.; Divgi, C. R.; Zelenetz, A. D.; Humm, J.; Abrey, L. E.
    Cancer (2007)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions
    Meeting Abstract

    Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP chemotherapy for mantle cell lymphoma is a safe and highly effective regimen
    Meeting Abstract

    Zelenetz, A.; Donnelly, G.; Pandit-Taskar, N.; Humm, J.; Divgi, C.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Initial treatment of mantle cell lymphoma with sequential radioimmunotherapy with Tositumomab/Iodine I131 I-Tositumomab followed by CHOP chemotherapy results in a high complete remission rate
    Meeting Abstract

    Zelenetz, A. D.; Donnelly, G.; Halaas, J.; Sgouros, G.; Humm, J.; Popplewell, L.; Reyes, S.; Maignan, K.; Campbell, C.; Moskowitz, C. H.; more...
    Blood (2003)

    Fulltext@MSK | Save